Hydroxyl and Peroxyl Radical Trapping by the Monoamine Oxidase-B Inhibitors deprenyl and MDL 72,974A: Implications for Protection of Biological Substrates
- 1 January 1997
- journal article
- Published by Elsevier in Free Radical Biology & Medicine
- Vol. 22 (4) , 733-737
- https://doi.org/10.1016/s0891-5849(96)00402-9
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Rationale for (−)deprenyl (selegiline) medication in Parkinson's disease and in prevention of age-related nigral changesBiomedicine & Pharmacotherapy, 1995
- Oxidative stress: Free radical production in neural degenerationPharmacology & Therapeutics, 1994
- In Vivo Generation of Hydroxyl Radicals and MPTP‐Induced Dopaminergic Toxicity in the Basal GangliaAnnals of the New York Academy of Sciences, 1994
- Apparent antioxidant effect of l-deprenyl on hydroxyl radical formation and nigral injury elicited by MPP+ in vivoEuropean Journal of Pharmacology, 1993
- Ascorbate and phenolic antioxidant interactions in prevention of liposomal oxidationLipids, 1992
- MDL 72,974: a potent and selective enzyme-activated irreversible inhibitor of monoamine oxidase type B with potential for use in Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- Fluorescence‐based assay for reactive oxygen species: a protective role for creatinineThe FASEB Journal, 1988
- The deoxyribose method: A simple “test-tube” assay for determination of rate constants for reactions of hydroxyl radicalsAnalytical Biochemistry, 1987
- Thiobarbituric acid‐reactivity following iron‐dependent free‐radical damage to amino acids and carbohydratesFEBS Letters, 1981
- Vesicles of variable diameter prepared by a modified injection methodBiochemistry, 1977